Effect of Aronia Berry Consumption on Inflammatory Parameters

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorAmasya University

About this trial

The study will aim to evaluate the effects of consuming freeze-dried aronia berries as an adjunct to medical treatment in patients with chronic obstructive pulmonary disease (COPD), focusing on anti-inflammatory, respiratory, and biochemical parameters.

It will be conducted at a research hospital in Istanbul, involving 50 participants aged 50-80 diagnosed with COPD. Participants will be randomly assigned to two groups: the aronia group (AG, n=25) and the placebo group (PG, n=25). The AG will receive 30 g of freeze-dried aronia powder daily, while the PG will receive 30 g of placebo powder, both for a duration of 8 weeks. Baseline demographic data will be collected through face-to-face interviews, while biochemical, respiratory, anthropometric, and body composition parameters will be assessed both before and after the intervention. Dietary intake records will also be collected and analyzed.

Eligibility criteria

Qualifiers

Aged 50-80 years

Diagnosed with COPD

Not following a vegetarian or vegan diet

Willing to consume the provided aronia berry (black chokeberry)

Disqualifiers

Presence of associated chronic inflammatory/rheumatic diseases

Chronic infections that may create a prothrombotic state

Chronic kidney disease (CKD)

Malignancy

Trial design

Treatments tested in this trial

  • Black chokeberry (Aronia melanocarpa)
  • Placebo powder

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators